1. Introduction
Primary central nervous system lymphoma (CNSL) is a relatively uncommon form of tumor in dogs and is rare in cats, accounting for approximately 4% of all canine lymphomas [1] and less than 3% of cats with primary CNS tumors [2]. Lymphoma within the CNS develops most commonly as part of a multicentric process in both species with a reported prevalence up to 12% [3] or even nearly 30% [4] in dogs, and 7.8% [2] to 14.4% [5] in cats.
CNSL is believed to be more common in adult dogs with a mean age of onset of 7.4 years (range 3–11). Although there is no breed predisposition, Rottweiler dogs seem to have a slightly higher risk of developing CNS lymphoma [3,6]. The mean age of cats with prevalent location in the spinal cord is reported to be 6.3 years (range 2–8) [7] and no breed prevalence is recognized, with domestic shorthair cats being the most represented [2,5,8].
Peripheral nervous system lymphoma (PNSL) is less commonly encountered than CNSL. In dogs, it is mostly secondary [9,10,11,12,13], whereas in cats the primary type is most frequently recorded [2,8,14,15,16,17,18] and is considered the most common secondary tumor involving the PNS [15,19]. However, the incidence of both CNS and PNS lymphoma may vary depending on the tumor location in the neuraxis and spinal and cranial nerves [20,21].
The phenotype in canine CNSL is almost equally represented between B-cell [4,20,22,23,24,25,26,27] and T-cell [4,20,24,26,27,28,29,30,31,32,33,34], and less than 4% are reported as non-B non-T cell. B-cell lymphoma, especially diffuse large B-cell lymphoma, predominates in secondary types [26]. In cats, B-cell lymphoma [2,8,18,21,24,35,36,37,38,39,40] is more frequently detected than T-cell lymphoma [2,8,17,18,21,41,42,43].
Studies reporting a consistent number of cases with detailed neurolocalization and lesion distribution, as well as pathological patterns and immunophenotyping, are limited, with most of the existing literature being represented by case reports with fragmented information and therefore not always comparable. Given the lack of consistency in the evaluation of nervous system lymphoma in previous studies, the aims of this retrospective study were to determine the specific location, pathological patterns, phenotype, and prevalence of primary versus secondary, central and peripheral nervous system lymphomas in dogs and cats, evaluating 92 cases and comparing the results with the available literature.
2. Materials and Methods
2.1. Caseload
Ninety-two cases of central and peripheral nervous system lymphoma diagnosed between 1994 and 2022 (45 in dogs and 47 in cats) were retrieved from the archive of the Neuropathology Laboratory of the Department of Veterinary Sciences of Pisa University. Signalments including breed, age, gender, main neurological signs, and tissue sample origin (biopsy or necropsy) are reported in Table 1. Specimens were obtained either from surgical biopsy or post-mortem examination and routinely formalin-fixed and paraffin wax-embedded and processed for histology. For each case, the type (primary or secondary/multicentric), the anatomical sites (intracranial, intraspinal, cranial, and spinal nerves), and the precise location and distribution were also recorded. In primary neoplasia cases, the extra-neural system involvement was assessed clinically or after complete post-mortem examination in case of death, as previously reported by other authors [2,8].
2.2. Histopathology and Immunohistochemistry
Four-µm tissue sections were stained with hematoxylin and eosin (H&E), Luxol fast blue, and immunohistochemical methods. The histological classification and grading of the tumors were assessed according to the World Health Organization criteria [44]. Immunoperoxidase was performed using a rabbit polyclonal antibody anti-human-CD20 (1:200, Thermoscientific, Fremont, CA, USA) and a rat monoclonal antibody anti-human-Paired Box 5 (PAX5, 1:250, Abcam, Cambridge, MA, USA) as B-cell markers, and a rabbit polyclonal antibody anti-human-CD3 (1:200, Dako, Glostrup, Denmark) as T-cell marker. Antigen retrieval for CD3 and PAX5 was performed by heat-induced epitope retrieval in citrate buffer at pH 6.0. No retrieval was performed for anti-CD20 antibody. Sections were pretreated with 1% H2O2 in PBS for 10 min to quench endogenous peroxidase activity, then rinsed with 0.05% Triton-X (TX)-100 in phosphate-buffered saline (PBS) (3 × 10 min) and blocked for 1 h with 5% normal horse serum (PK-7200, Vector Labs, Burlingame, CA, USA) in PBS. The sections were then incubated overnight at 4 °C in a solution of the antibodies with 2% normal horse serum and 0.05% TX-100 in PBS. Sections were then rinsed in PBS (3 × 10 min), incubated for 20 min with universal biotinylated anti-mouse/rabbit IgG (Vectastain Kit, PK-7200, Vector Labs), and then with ABC reagent (Vectastain Kit, PK-7200, Vector Labs). Sections were again rinsed in PBS (3 × 10 min). The immunoreactivity was detected by the streptavidin-biotin peroxidase method (Streptavidin Peroxidase, ThermoFisher Scientific, Fremont, CA, USA), using 3,3′-diaminobenzidine as chromogen. Negative controls were obtained by replacing the primary antibody with an irrelevant, isotype-matched antibody and with an anti-serum. Canine and feline normal lymph nodes were used as positive control.
2.3. Pathological Patterns
Based on the histopathological location and distribution, the tumors were divided into the following pathological patterns: intraparenchymal mass (IP) (or intramedullary when in the spinal cord; IM), extraparenchymal (comprising both meningeal masses and leptomeningeal lymphomatosis; MM and LL, respectively), intravascular (IVL), lymphomatosis cerebri (LC), extradural (ED), intradural-extramedullary (ID-EM), and involving cranial and/or spinal nerves. In this latter condition, the term neurolymphomatosis (NL) was adopted, based on the presence of an infiltrating monomorphic population of malignant lymphoid cells within the endoneurium and perineurium of peripheral nerves [10,11]. To compare our results with the literature, we grouped the affected nerves in four compartments: (1) cranial nerves; (2) brachial plexus and/or its branches; (3) spinal roots, spinal nerves, and spinal ganglia; and (4) sciatic plexus and/or its branches. Additional localization of neoplastic cells included choroid plexus, pituitary gland, and surrounding soft tissue of spinal cord and nerves.
3. Results
Dogs affected by lymphoma had a mean age of 6.8 ± 3.8 years (ranging from 10 months to 14 years). There were 24/45 (53.3%) males and 21/45 (46.7%) females. Ten dogs were mixed breed, while the remaining were pure breed, namely Labrador Retriever (n = 5), Boxer (n = 4), German Shepherd (n = 3), Cane Corso (n = 3), Border Collie (n = 2), Hound (n = 2), Rottweiler (n = 2), and one of each of the following breeds: Epagneul Breton, Golden Retriever, Shih-tzu, Bulldog, West Highland White Terrier, Yorkshire Terrier, Dachshund, Beagle, Staffordshire Terrier, Bergamasco Shepherd, English Cocker Spaniel, Amstaff, Great Dane, and Pointer.
Cats affected by lymphoma had a mean age of 8.3 ± 4.4 years (ranging from 3 months to 15 years). There were 22/47 males (46.8%) and 25/47 females (53.2%). Most of the cats were European Shorthair (n = 40), while the remaining seven cats belonged to the following breeds: Persian, Ragdoll, Maine Coon, Norwegian Forest Cat, Carthusian, Siamese, and European Longhair.
The type, anatomical site, location, distribution, pathological pattern, nuclear size, grading, and immunophenotype of the lymphomas affecting the 92 animals are summarized in Table 2.
In dogs, 22/45 (48.9%) lymphomas were intracranial, 14/45 (31.1%) were located within the spinal canal, and 9/45 (20%) were limited to the peripheral nervous system (PNS). In four cases, a simultaneous CNS and PNS involvement was observed. In cats, 24/47 (51%) lymphomas were located intracranially, 21/47 (44.7%) in the spinal canal, and 7/47 (14.9%) in the PNS. Within these cases, in three cats lymphoma was detected both in the brain and spinal cord, and in another two cats in the brain together with cranial and spinal nerves. A total of 24/45 (53.3%) canine lymphomas were classified as primary forms, and 21/45 (46.7%) had multicentric involvement. In cats, 27/47 (57.4%) and 20/47 (42.6%) lymphomas were classified as primary and multicentric forms, respectively. Regarding the phenotype, the majority (24/45; 53.3%) of canine lymphomas had a B-cell phenotype, while 15/45 (33.3%) a T-cell phenotype, and 6/45 (13.4%) were non-B non-T cell lymphoma. In feline lymphomas, 25/47 (53.2%), 18/47 (38.3%), and 4/47 (8.5%) had B-cell, T-cell, and non-B non-T cell phenotypes, respectively.
3.1. Intracranial Lymphoma
The 27% (6/22) of canine and 20.8% (5/24) of feline intracranial lymphomas consisted of an intraparenchymal neoformation primarily but not exclusively located in the forebrain in both species (Figure 1A), and mostly as part of multicentric lymphoma in both dogs (five out of six; 83.3%) and cats (three out of five; 60.0%).
Grossly, focal or multifocal, whitish-grey masses accompanied by swelling of the peritumoral parenchyma and occasionally hemorrhagic areas were observed. The histopathological pattern was characterized by dense sheets of perivascularly arranged malignant cells that invaded the surrounding neuroparenchyma, creating highly cellular areas (Figure 1B). In one cat (#46), the neoplastic infiltration involved both the optic nerves and extended into the diencephalon. B-cell, T-cell, and non-B non-T phenotypes were observed in both species. In dogs, four out of six (66.7%) cases were B-cell, one out of six (16.7%) was T-cell, and one out of six (16.7%) was non-B non-T cell lymphoma. In cats, three out of five (60.0%) were T-cell and two out of five (40.0%) were B-cell lymphomas.
In one dog (#39), there was a grayish discoloration of large areas of the telencephalic white matter associated with bilateral loss of distinction between gray and white matter (Figure 2A). Moreover, there was a blurring appearance of the hippocampal layers and cerebral sulci. No space-occupying lesions were detected in any areas of the brain. Histopathologically, the neoplastic cells diffusely infiltrated the white matter tracts and the perivascular spaces (Figure 2B) and showed large, round nuclei with a thin rim of slightly eosinophilic cytoplasm. Anisokaryosis was moderate with two to three mitoses for high power field (HPF, 400×, 2.37 mm2), and apoptotic figures were observed. Frequently, neurons were normal, even if extensively surrounded by neoplastic cells. Most malignant cells were positively immunolabelled with anti-CD3 marker and a small number of CD20-positive B-lymphocytes were observed within the perivascular cell infiltrate (Figure 2C,D). Within the most severely affected areas, there was activation and proliferation of microglial cells. The morphological features of this case were consistent with lymphomatosis cerebri (LC).
Almost half of the canine intracranial lymphomas (10/22; 45.4%) occurred as intravascular lymphoma (IVL), characterized by aggregation of neoplastic cells within the blood vessel lumen and scant invasion of the surrounding neuroparenchyma (Figure 3A). Multifocal thrombosis, hemorrhage, and necrosis of different regions of the brain were consistently associated with IVL. Detailed features of these 10 cases were reported in a previous study [45].
Intracranial lymphomas were characterized in many cases by prominent meningeal involvement, resulting in an extra-axial location (extra-axial lymphoma, EAL). Meningeal lymphoma was detected in 15/24 (58.3%) cats and in 2/22 (9.1%) dogs. These two canine tumors were multicentric, while 9/15 (60.0%) of feline cases were primary. This pathological pattern appeared as a well-defined, focal, irregular mass within the leptomeninges, resulting in a space-occupying lesion with compression of the underlying nervous tissue (Figure 3B). The cells exhibited mild to severe pleomorphism and typical lymphoid appearance. In most cases, despite well-defined margins, the meningeal masses were found in association with perivascular aggregates of neoplastic lymphoid cells within the neuroparenchyma, showing an intraparenchymal pattern. Both B-cell and T-cell phenotypes were observed in the two canine tumors. In cats, 9/15 of lymphomas had a B-cell phenotype (60.0%), whereas 4/15 (26.7%) and 2/15 (13.3%) showed a T-cell and non-B non-T phenotype, respectively. With regard to location, all feline tumors involved the forebrain, mainly the leptomeninges of the frontal lobes. Additionally, in two feline cases, the meningeal masses were associated with an intradural-extramedullary (#77) and an extradural (#79) spinal cord lymphoma.
Four cases of leptomeningeal lymphomatosis (LL) were observed; two were in dogs and two were in cats. In this pattern, neoplastic lymphocytes showed widespread diffusion predominantly within the subarachnoid space, infiltrating in some cases the subpial neuroparenchyma and perivascular spaces (Figure 4A). The canine forms were a multicentric T-cell lymphoma affecting the brain (#40) and a multicentric B-cell lymphoma restricted to the spinal cord (#35). The feline forms were a primary T-cell intracranial neoplasia (#88) and a multicentric B-cell lymphoma affecting both the brain and the spinal cord (#49, Figure 4B).
3.2. Intraspinal Lymphoma
Extradural (ED) and intramedullary (IM) pathological patterns of spinal cord lymphoma (SCL) were observed in both species. A total of 81% (17/21) of all feline SCL described in this study were ED lymphomas, represented by 47% (8/17) primary lymphomas and 53% (9/17) multicentric. The thoracolumbar segment was most affected (10 cases), including one cat (#79) with multifocal meningeal involvement of the brain and thoracic spinal cord. Canine ED lymphoma was recorded in 9/14 (64.3%) of all canine SCLs. A total of 33.3% (three out of nine) were primary, while 66.7% (six out of nine) were multicentric.
The lesions were usually non-encapsulated, poorly defined, soft, grayish masses within the epidural fat, often with secondary severe spinal cord compression (Figure 5A). In some cases, the tumor infiltrated and invaded the adjacent vertebral bodies or soft tissues. The meninges and spinal cord parenchyma were focally invaded. Most of the diffuse neoplastic infiltration in the epidural fat was composed of large, rounded to oval lymphoblastic cell sheets (Figure 5B). B-cell lymphoma was the most frequently observed phenotype in primary types, both in dogs (three out of three; 100%) and in cats (six out of eight; 75.0%). As for secondary extradural lymphomas in dogs, four out of six (66.7%) were B-cell and two out of six (33.3%) were T-cell lymphomas. In cats, five out of nine (55.6%) were B-cell and four out of nine (44.4%) were T-cell.
Intradural-extramedullary lymphoma was observed in only three (3/21; 14.3%) feline cases, either as a primary or multicentric form. They were all T-cell lymphomas located in the thoracolumbar segment. One of them was associated with a cerebral meningeal mass (#77). In one dog (#35), diffuse intradural-extramedullary neoplastic infiltration was observed throughout the entire spinal cord, showing a pattern consistent with LL.
Intramedullary lymphoma was recorded in 4/14 (28.6%) of canine cases. Two intramedullary tumors were primary lymphoma B-cell and non-B non-T cell phenotypes, and two multicentric lymphomas showed sciatic nerve involvement and lumbosacral intra-medullary invasion (#5 and #9). A primary, non-B non-T cell lymphoma was observed in only one cat (#65).
3.3. Peripheral Nervous System Lymphoma
Lymphoma of the peripheral nervous system (or neurolymphomatosis, NL) was observed in 13/45 dogs (28.9%), in two of which it was associated with an intracranial mass and one with concurrent spinal cord neoplasia. Of these cases, 7/13 (53.8%) were males and 6/13 (46.2%) were females. The mean age of dogs with NL was 7.4 ± 3.1 years (ranging from 2.5 to 14 years). There was no breed prevalence: four dogs were mixed breed, and the remaining dogs belonged to the following breeds: Great Dane, Hound, Golden Retriever, Bulldog, Staffordshire Terrier, Amstaff, Cane Corso, Rottweiler, and Labrador Retriever. Eight out of 13 cases (61.5%) were primary lymphomas, while the remaining 5/13 (38.5%) were multicentric. As for neurolocalization, in 7/13 (53.8%) cases the tumor involved the sciatic nerve and/or its branches, in 4/13 (30.8%) cases the spinal roots, spinal nerves and spinal ganglia (i.e., L1, L5, L6 nerves and one case multiple nerves), while in the remaining two cases (15.4%) it involved the trigeminal nerves (Figure 6A,B). Histopathologically, NL was characterized by widespread infiltration of malignant lymphoid cells within the endoneurium and perineurium (Figure 6C). By immunohistochemistry, 6/13 (46.2%) cases were T-cell lymphomas and 7/13 (53.8%) were B-cell lymphomas.
In the feline cases, NL was detected in 7/47 (14.9%) cases, two of which were associated with an intracranial mass. Of these cases, three out of seven (42.9%) were males and four out of seven (57.1%) were females. The age of cats with NL varied widely, ranging from 3 months to 14 years; there was no breed prevalence, as four cats were European Shorthair and the remaining were a Ragdoll, a Carthusian, and an ELH cat. Five out of seven cases (71.4%) were primary lymphomas. As regards the localization, in two cases (#82 and #89) the neoplasm involved both the cranial and spinal nerves. Looking at each compartment individually, in three cases the neoplasm involved the sciatic plexus and/or its branches, and the same occurrence was recorded for spinal roots, spinal nerves, and spinal ganglia. In two cases, NL was observed in cranial nerves, and in another two cases the brachial plexus and/or its branches were involved. By immunohistochemistry, four out of seven (57.1%) cases were B-cell and three out of seven (42.9%) were T-cell lymphomas.
4. Discussion
In our study, nervous system lymphoma occurred at any age in dogs and cats, from 3 months to 15 years, but was most common in middle-aged animals, as previously described [5,8,18,26]. Similarly, our results support that there is no breed or gender predisposition, except in dogs, where five (11%) Labrador Retrievers were affected. Neurological signs were present in each patient and were highly variable, depending on the anatomical location of the tumor [20,21]. Both peripheral and central nervous system involvement were identified, and nine different pathological patterns of nervous system lymphoma (intraparenchymal mass, lymphomatosis cerebri, intravascular lymphoma, meningeal mass, leptomeningeal lymphomatosis, extradural, intradural-extramedullary, intramedullary, and neurolymphomatosis) were recorded and will be discussed in this section.
4.1. Intracranial Lymphoma
Intracranial lymphoma can involve the brain parenchyma and/or meninges as focal, multifocal, diffuse, and intravascular lesions, showing different histopathological patterns.
4.1.1. Intraparenchymal Patterns
Intraparenchymal lymphomas (IPLs) are commonly reported in feline nervous system lymphomas [2,5,8,24,35,36,37,39,40,46,47,48] and less frequently in the canine counterpart as either primary or multicentric types [3,24,25,26,28,48]. There are currently insufficient data to support a different localization between primary and multicentric tumors; therefore, a thorough post-mortem examination remains mandatory to distinguish these two forms [2]. Rostrotentorial regions such as the cerebral cortex [2,25,36,48,49], diencephalon [1,5,8,28,37], and the olfactory bulb [5,8,48] are the most targeted brain sites. Although considered rarer, cerebellar location has also been described [1,2,4,20,27,40,50].
In our study, canine IPL was observed in the occipital lobe, ponto-cerebellar angle, basal nuclei, thalamus, and parieto-occipital lobe with trigeminal nerve involvement. In cats, no preferred sites were identified, with both the forebrain and hindbrain regions involved. IPLs were mainly multicentric, and no breed or gender predisposition was identified in both species. The mean age of the dogs of our study was 6.8 years, in accordance with previously reported data (from 5.5 to 7.4 years) [1,48]. As noted in this study, where the mean age at diagnosis was 10 years, affected cats are usually reported to be adult or elderly [2,37,48,51].
The distribution of neoplastic cells and the invasion of the neuroparenchyma were similar to those reported in the literature [24,25,28,49]. Lymphoma is usually composed of heterogeneous soft tissue with a whitish-gray appearance and is occasionally associated with small malacic foci [36,49]. Adjacent tissue may be swollen, and multifocal lesions are described [5,48]. Both T-cell [2,24,26,28] and B-cell [8,24,25,35,36,37,40,46] CNSLs have been described in the literature as in this study.
4.1.2. Lymphomatosis Cerebri
The term “lymphomatosis cerebri” (LC) is used to describe an atypical neuroanatomical pattern of lymphoma cell spread [52]. This variant is not so uncommon in the feline species [5,49]. The absence of a cohesive mass is the most notable histological feature of LC. Lymphoid cells spread widely and diffusely mainly within the cerebral white matter from the frontal lobe to the brainstem and spinal cord [3,49,53,54]. Focal leptomeningeal congestion and dilation of the lateral and third ventricles and central canal have also been described [42,54]. Feline LC is always described as a T-cell primary form, although large granular T-cell lymphoma, presumably originating in the alimentary tract with a secondary diffuse infiltrate in the white matter of the brain, has been reported [43]. No breed, age or gender predisposition has been identified [42,54]. In human medicine, no differences in the distribution ratio between sexes have been reported and B-cell LC account for most cases [55,56].
There are no reports of LC in dogs in the veterinary literature. In our case series we described a novel finding of a primary and diffuse infiltration of neoplastic T-cells within the white matter and leptomeninges in one dog that was consistent with LC. No cases of LC in cats were observed in our study.
4.1.3. Intravascular Lymphoma
Intravascular lymphoma (IVL), also known as “angiotropic lymphoma”, is a rare type of lymphoma that has been reported in both humans [57,58] and animals [26,29,34,45,59,60]. This form is characterized by the predominant growth of neoplastic cells within the lumen of blood vessels with little or no extension into the neuroparenchyma. Progressive occlusion of blood vessels with neoplastic cells leads to thrombosis, hemorrhage, and infarction. Various organs could be affected [61,62], but nervous system involvement is the most frequently reported in the literature, both in humans and domestic animals [26,29,34,45,49,60,63]. In dogs, IVL has been described in 10 reports including a total of 51 dogs [26,29,34,45,59,60,63,64,65,66]. In those IVL cases, there was either a restricted involvement of the brain or it was part of a multiorgan/multicentric IVL form. In our study, 10 cases of IVL were observed, representing almost half of the canine intracranial lymphomas. Affected animals were middle-aged dogs with a mean age of 8 years (ranging from 2.5 to 13 years), slightly above what was previously described in two studies (mean age of 7.25 and 6, respectively) [34,59]. In accordance with the literature, no breed or sex predilection was observed in our cases. Although reported in previous studies [29,34,59,66], no spinal cord involvement was detected in our IVL cases, where the lesions were restricted to the brain. The histopathological lesions observed in the affected brain regions were similar to the ones described in previous studies on canine IVL [29,34,59,66]. In our cases, the non-B non-T phenotype was identified in four IVL cases with a prevalence similar to that reported in a previous study [59]. Although the T-cell IVL phenotype was the most prevalent in previous studies [29,59,63], in our remaining six cases there was an equal distribution of T-cell and B-cell IVL.
There were four reports of IVL in cats [8,61,67]. In two of them, the vascular lesions were limited to the brain [8], in one case to the brain and kidneys [67], and in only one case as systemic disease. No gender or breed predisposition for feline IVL was reported in those studies. No cases of feline IVL were recorded in our series.
4.1.4. Extraparenchymal Patterns
Extraparenchymal (or extra-axial) lymphoma (EAL) may appear as a well-defined focal mass involving the meninges but may also diffusely invade the leptomeninges and choroid plexuses, resulting in “leptomeningeal lymphomatosis” and “lymphomatous choroiditis”, respectively [8]. Meningeal masses (MM), unlike intraparenchymal ones, are usually well-defined. They may be irregularly shaped with a whitish-gray appearance and soft texture. Sporadic malacic and hemorrhagic foci are mentioned [49,68].
In this report, intracranial extraparenchymal lymphomas in cats were mainly characterized by meningeal location, usually accompanied by secondary infiltration of the neuroparenchyma. This is a frequent condition in cats, accounting for 30 to 100% of intracranial lymphomas [5,18,21,48], as a primary or multicentric type [48]. Feline EAL was diagnosed more commonly than IPL in our series, primarily as primary types. This pathological pattern is less frequent in dogs and has been reported in a few cases [31,48]. Additionally, in our series only two dogs had an occipito-temporal meningeal lymphoma and a multifocal meningeal infiltration also involving the thalamus, cerebellum, medulla oblongata, choroid plexus, and pituitary gland.
In cats, most tumors described by Mandara et al. (2022) [8] were within the cranial fossa. Interestingly, all feline MM in our study were in the forebrain, with the frontal lobe being the most common site. The median age of cats was 11 years (ranging from 4 to 17), with ESH as the main represented breed in accordance with the existing literature [5,8,38]. Based on the immunohistochemistry results, most intracranial meningeal masses in our feline cases were B-cell lymphomas, as reported in previous studies [8,38].
EAL may also develop in the choroid plexus (CP) and either grow to a recognizable mass [27,68] or lead to diffuse neuroparenchymal infiltration [8,18,26,30]. In both human and veterinary medicine, the latter variant, known as “lymphomatous choroiditis,” is sporadically documented [27,68].
In our series, four and two cases with CP involvement were observed in dogs and cats, respectively. However, neoplastic lesions within the CP were always associated with lymphoma spread to other CNS or PNS locations, both as primary and multicentric forms.
An additional neuroanatomical growth pattern of extraparenchymal lymphoma is intradural lymphoma. In humans, an uncommon subtype of primary CNSL that develops from the dura mater and differs considerably from other CNSLs is called primary dural lymphoma. This tumor is classified as a mucosa-associated lymphoid tissue (MALT) lymphoma and is typically indolent [69,70]. However, secondary involvement of the dura and leptomeninges is reported [71]. In veterinary medicine, pachymeningeal lymphoma is poorly documented, and Mello et al. [18] reported the lone occurrence of intradural lymphoma in cats. In our case series this pathological pattern was not observed.
4.1.5. Leptomeningeal Lymphomatosis
When neoplastic lymphocytes show prevalent diffuse infiltration of the subarachnoid space, this pathological pattern is referred to as leptomeningeal lymphomatosis (LL), or lymphomatous meningitis, and has been reported in dogs and cats [8,49,72]. In some reports it has been considered as a secondary evolution of an extra-nervous lymphoma [32,72], or as a primary form [22,23,30,41,73]. Neoplastic lymphocytes are thought to directly extend from pre-existing primary or metastatic CNS tumors, from an extra-CNS mass invading the PNS, or through hematogenous dissemination into the leptomeningeal structures [72,74]. However, since primary forms have been reported, the etiopathogenesis of LL remains unknown. Being frequently described alongside neoplastic infiltrates occurring in the nervous tissue, such as neurolymphomatosis [2,8] or parenchymal and periventricular infiltrates [43,54], this form represents a diagnostic challenge [72].
In the present study, two cases of canine LL (2/45; 4.4%) were detected as a multicentric form: one was found in the cerebral and cerebellar lobes, and the other involved the meninges of the entire spinal cord. Canine LL is reported to be composed of T-cell [30,31] or B-cell [23,26] phenotypes. Both T-cell and B-cell phenotypes were represented in our study.
Recently, Mandara et al. (2022) [8] described three cases of primary feline LL: one case with involvement limited to the brain, one to the spinal cord, and one with a pathological continuum between brain LL and neurolymphomatosis of the optic chiasm, all affecting DSH adult/elderly cats. Feline LL was also described in primary [2] and in secondary brain lymphoma [18] as the most frequent pathological intracranial pattern. In our study, two cases of LL were observed in cats with occasional leptomeningeal thickening. One of these was primary and limited to the brain meninges, while the second was a multicentric type affecting both the brain and spinal cord.
The feline primary form described in our series was T-cell lymphoma. Notably, five out of seven primary LL described in the literature were classified as T-cell lymphoma [2,8,41]. The two B-cell primary LL described in the literature showed rare oculo-cerebral involvement [8,73]. Further studies are needed to assess whether there is an association between the phenotype and this location. Regarding LL as part of multicentric lymphoma in cats, both B-cell and T-cell phenotypes have been reported [17,18,72].
4.2. Intraspinal Lymphoma
Lymphoma within the vertebral canal (or intraspinal lymphoma, SCL) can be categorized into three main forms with distinct biological characteristics based on anatomical location within the vertebral canal and spinal cord involvement [7,49]. Extra-axial lesions may be external to the dura mater (extradural; ED) or internal to the dura mater but external to the pia and spinal parenchyma (intradural-extramedullary; ID-EM). The SCL may also be located within the spinal cord parenchyma (intramedullary; IM) [14,75,76,77,78,79].
Most frequently, SCLs are reported as secondary [7,14,18]; however, primary forms are also described [2,7,8,14,17]. The mechanism of primary SCL formation is not fully understood; hematopoietic tissues of extramedullary or vertebral bone have been suggested as the site of origin of spinal lymphoma [7,14,80,81,82]. Spinal cord secondary lymphomas are thought to result from direct extension from the paravertebral regions through the vertebral foramen, or from hematogenous dissemination through the epidural venous system [83].
Canine SCL occurs almost as frequently as in cats. The most common location is extradural [20,22,32,33,48,79,80,81,84,85,86], followed by intramedullary [20,48,75,76], and less commonly intradural-extramedullary location [20,48]. In our study, SCL was more frequently detected in cats than in dogs, with the thoracolumbar location over-represented in both species.
Cats with spinal lymphoma are often younger than those with other spinal cord tumors [7]. In cats, the mean age at the time of diagnosis was highly variable, with 4.5 years (ranging from 8 months to 7 years) and 4 years (ranging from 1 to 11 years) for primary and secondary forms, respectively [14,77,87]. Similarly, age at diagnosis was variable in our study, with a comparable mean age between primary (5 years; range 0.7–12 years) and secondary (6 years; range 0.7–13 years) types. No gender or breed predisposition was found in our study, as in the series reported in the literature.
Clinical and pathological features of SCL may vary. It can manifest as a focal mass [14,32,33,77], multifocal masses, or extensively disseminated tumor [8,14]. The lumbosacral and thoracic segments are the preferential site of onset [32,33], but lymphoma has the potential to involve any segment of the spinal cord [8,14,18,20,79,87]. Furthermore, SCL is often reported in association with cranial [7,88] or spinal nerves [2,21,68,77] involvement, depending on the anatomical location.
4.2.1. Extradural Lymphoma
Our findings on ED lymphoma are comparable to those of previous studies, where ED lymphoma was the most frequently reported pattern of SCL, described as both primary and secondary type [7,14,20,22,32,33,48,68,77,80,81,84,85,86,89]. Both T-cell and B-cell phenotype were found, as previously reported [2,8,17,18,20,32,33,81,90,91]. Most of the primary ED lymphoma in our cats and all primary types in dogs were B-cell lymphomas, whereas the B and T phenotypes were equally represented in the multicentric types. Further studies on feline SCL phenotyping and its possible association with neuroanatomical patterns are warranted. Based on the limited data available, B-cell lymphoma seems to be the most prevalent phenotype in cats. Although numerous cases have been reported in dogs, immunophenotyping was performed in only a few of them [20,32,33,81], showing that the most frequent phenotype was T-cell.
4.2.2. Intradural-Extramedullary Lymphoma
In the present study, only one case of canine ID-EM lymphoma was found in a dog and three in adult cats. ID-EM has been reported in both species [7,20,88] as an irregular mass that fills the subdural and subarachnoid spaces and tends to infiltrate contiguous segments of the spinal cord or nerve roots [49,87]. In two primary intradural-extramedullary lymphomas, T-cell phenotypes were identified [2]. In our case series, all tumors were T-cell, and in one case it was associated with intracranial meningeal involvement.
4.2.3. Intramedullary Lymphoma
Intramedullary pattern is occasionally reported in dogs and cats, mainly as secondary SCL [7,20,76]. The tumor may appear as a soft, poorly defined mass or may produce neuraxis enlargement, altering the parenchymal architecture [2,7]. Hemorrhagic myelomalacia due to compression injury has been documented in cats in both intramedullary and extramedullary lymphomas [91,92].
In our study, four tumors in dogs and only one tumor in a cat were classified as intramedullary SCL. Given the few cases, no differences between primary and secondary forms were identified in both species. The feline tumor was a non-B non-T lymphoma. Notably, no intramedullary B-cell lymphomas have been reported in cats [8,17].
4.3. Peripheral Nervous System Lymphoma
Peripheral nerve lymphoma (or neurolymphomatosis, NL) is uncommon in dogs and rare in cats [12,15,51,93]. They can involve any cranial nerve, spinal nerve roots, somatic, or autonomic nerves [78,94,95,96]. The most frequently affected nerves are the trigeminal, those within the cervico-thoracic segment (C6-T2), and, more rarely, nerves of the lumbar intumescence [93]. The neoplasms may be confined to or extend along the nerves, resulting in an intradural-extramedullary location with spinal cord compression [97,98,99]. Multicentric NL is rarely reported in both human and animal species [12,100,101,102,103,104].
Macroscopically, the affected peripheral nerve may be normal or homogeneously thickened [105], soft, and have yellowish discoloration [18], mimicking inflammatory infiltration or the less common chronic hypertrophic neuritis [106]. Less frequently, a mass that focally deforms the nerve trunk can be observed, whereas in other cases, a large tumor mass is easily identifiable [16,107]. These masses are commonly described as solid, whitish, irregularly bosselated, and non-symmetric [103]. Complete nerve loss and replacement with a well-circumscribed white mass has also been reported [16]. In several cases, moderate atrophy of the muscles innervated by the affected nerves was the most significant gross lesion associated with NL [15,16,105,107].
In our study, the higher prevalence in dogs than in cats is in contrast with the data reported in the literature [2,8,9,10,11,12,13,14,15,16,18,101,105,107]. Our results showed no breed or gender predisposition in either dogs or cats and that NL typically affected adults. The mean age of dogs and cats with NL was similar to that reported in the literature. In dogs, the prevalence of the primary type was higher than the secondary, unlike what was reported in other studies, in which all cases were secondary types. Regarding the feline species, NL was primary in most of the cases, accordingly with previous studies [2,8,15,16,18,101]. The increase in the number of primary lymphoma diagnoses may be related to the development of veterinary neurology and neurosurgery referral services [8].
In our dogs, the sciatic nerve and/or its branches was the most affected of the compartments, followed by the spinal roots, spinal nerves and spinal ganglia, and the trigeminal nerve. Similar findings have been reported in the literature [10,11,12,13]. Results on the feline population showed that there was no predominance of one compartment over the others [2,8,14,15,16,18,101,103,105,107]. Optic nerve involvement may be more frequent in cats [8]. Moreover, PNS involvement with and without concurrent CNS involvement are findings similar to those reported in the literature [2,8,9].
Data on phenotype are still fragmentary in veterinary medicine, as the only data are single case reports or small cohorts. Our results showed that there is no predominance of one phenotype over the other, but B- and T-cells lymphomas are equally distributed among population in both dogs and cats. These results are in line with the literature [2,8,14,15,16,18,101,103,105,107].
5. Conclusions
In this retrospective study we evaluated 92 cases of central and peripheral nervous system lymphoma in dogs and cats, which were studied on the basis of consistent histopathological and immunohistochemical examination. An extensive literature review was performed to collate available information on reported cases and reconcile fragmented clinical and pathological data so that our results could be compared with the available literature.
In our study, no age, breed, or gender predisposition related to specific CNSL subtypes was seen in both species, even if in Labrador Retriever dogs it occurred with a slightly higher prevalence. The lone exception was the occurrence of SCL in juvenile cats, as previously reported. The overall anatomical locations of CNSL vs. PNSL, type (primary vs. secondary/multicentric), and phenotypes were similar across the species.
Regarding CNSL, the forebrain was the most frequent site of lymphoma in dogs and the thoracolumbar segment was the most frequent site in cats. Primary CNSL in cats most frequently involved the forebrain meninges and, to a lesser extent, the optic nerves, especially as a B-cell phenotype. Extradural location was the most prevalent pathological pattern of SCL in both species. The B-cell phenotype predominated in primary lymphoma, whereas the B-cell and T-cell phenotypes were equally represented in the multicentric type.
PNSL most frequently affected the sciatic nerves and its branches in dogs, whereas no prevalent compartment was recognized in cats. B-cell and T-cell phenotypes were equally represented in primary and multicentric PNSL in both species.
Canine intravascular lymphoma mimicked a neurovascular condition rather than space-occupying or inflammatory lesions. Lymphomatosis cerebri can also occur in dogs.
Clinicopathological features were variable in both species, particularly in neurolymphomatosis, due to different combinations of central and peripheral nervous system involvement.
Author Contributions: Conceptualization, C.C.; Methodology, N.F., F.P., Ç.A. and S.D.; Valida-tion, C.C.; Investigation, N.F., F.P., Ç.A. and S.D.; Data curation, N.F., F.P., Ç.A. and S.D.; Writing—original draft, N.F., F.P. and Ç.A.; Writing—review & editing, S.D. and C.C.; Supervision, C.C. All authors have read and agreed to the published version of the manuscript.
Ethical review and approval were waived for this study because the reported cases are descriptions of clinicopathological cases of spontaneous disease. Written informed consent was obtained from the owners for the participation of their animals in the diagnostic procedures.
Not applicable.
Not applicable.
We thank Lisa Baroncini for expert technical assistance in histopathology. This study follows the research topics as foreseen by the OSCAR project of the Department of Veterinary Sciences of the University of Pisa.
The authors declare no conflict of interest.
| I | Primary form |
| II | Secondary/multicentric form |
| C | Cervical spinal cord |
| cn | Canine |
| CNS | Central nervous system |
| CNSL | Central nervous system lymphoma |
| CP | Choroid plexus |
| CT | Cervicothoracic spinal cord |
| EAL | Extra-axial lymphoma |
| ED | Extradural |
| ELH | European Longhair cat |
| ESH | European Shorthair cat |
| F | Female |
| FL | Forelimbs |
| fn | Feline |
| HL | Hindlimbs |
| IC | Intracranial |
| ID-EM | Intradural-extramedullary |
| IM | Intramedullary |
| IP | Intraparenchymal mass |
| IPL | Intraparenchymal lymphoma |
| IVL | Intravascular lymphoma |
| L | Lumbar spinal cord |
| LC | Lymphomatosis cerebri |
| LL | Leptomeningeal lymphomatosis |
| M | Male |
| MM | Meningeal mass |
| NL | Neurolymphomatosis |
| NM | Neutered male |
| NSL | Nervous system lymphoma |
| PG | Pituitary gland |
| PNS | Peripheral nervous system |
| PNSL | Peripheral nervous system lymphoma |
| S | Sacral spinal cord |
| SC | Intraspinal |
| SCL | Intraspinal lymphoma |
| SF | Spayed female |
| T | Thoracic spinal cord |
| TL | Thoracolumbar spinal cord |
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Signalment, main neurological signs, and tissue sample origin of 92 cases of canine and feline central and peripheral nervous system lymphoma.
| Case# | Species | Breed | Sex | Age | Neurological Signs | Tissue Origin |
|---|---|---|---|---|---|---|
| 1 | cn | Border Collie | F | 2 y | no menace response, nystagmus, trigeminal paralysis | necropsy |
| 2 | cn | Mixed breed | M | 10 m | paraparesis, back pain | biopsy |
| 3 | cn | German Shepherd | F | 8 y | acute paraparesis | necropsy |
| 4 | cn | Cane Corso | SF | 5 y | ataxia, depression, strabismus, left hemiparesis | necropsy |
| 5 | cn | Great Dane | M | 2.5 y | monoparesis, cauda equina syndrome | necropsy |
| 6 | cn | Mixed breed | F | 6 y | monoparesis | biopsy |
| 7 | cn | Cane Corso | M | 1 y | paraparesis | biopsy |
| 8 | cn | Epagneul Breton | M | 2 y | absent menace response, mydriasis, ataxia, head tilt | necropsy |
| 9 | cn | Hound | F | 7 y | progressive weakness, ataxia, ascending paresis | necropsy |
| 10 | cn | Golden Retriever | M | 7 y | multifocal intracranial syndrome | necropsy |
| 11 | cn | Shih-tzu | M | 8 y | ataxia, tetraparesis, no menace response, absence of pupillary light reflex | necropsy |
| 12 | cn | Bulldog | M | 4 y | right HL monoplegia | biopsy |
| 13 | cn | Mixed breed | SF | 7 y | acute and progressive paraparesis | biopsy |
| 14 | cn | West Highland White Terrier | M | 4 y | forebrain syndrome, blindness | necropsy |
| 15 | cn | Labrador Retriever | NM | 12 y | paraplegia | necropsy |
| 16 | cn | Labrador Retriever | M | 6 y | tetraparesis | necropsy |
| 17 | cn | Yorkshire Terrier | M | 7 y | paraparesis | necropsy |
| 18 | cn | Border Collie | SF | 13 y | right head tilt, brainstem syndrome | necropsy |
| 19 | cn | Beagle | M | 7 y | acute paraparesis | necropsy |
| 20 | cn | Mixed breed | M | 10 y | cervical pain, tetraparesis | necropsy |
| 21 | cn | Staffordshire Terrier | F | 6.5 y | ↓ menace response, masticatory muscles atrophy, ↓ facial sensitivity | necropsy |
| 22 | cn | Labrador Retriever | F | 3 y | left HL monoplegia, right HL monoparesis | necropsy |
| 23 | cn | Mixed breed | M | 4.5 y | paraparesis | biopsy |
| 24 | cn | Rottweiler | M | 2 y | depression, ataxia, no menace response, anisocoria, ↓ facial sensitivity | necropsy |
| 25 | cn | Labrador Retriever | M | 7 y | forebrain syndrome | necropsy |
| 26 | cn | Bergamasco Shepherd | M | 7 y | paraparesis, severe depression | necropsy |
| 27 | cn | Boxer | F | 3.5 y | forebrain syndrome | necropsy |
| 28 | cn | English Cocker Spaniel | M | 11 y | forebrain syndrome | necropsy |
| 29 | cn | Boxer | F | 4 y | intracranial multifocal syndrome, seizures | necropsy |
| 30 | cn | Pointer | M | 13 y | paraparesis, depression | necropsy |
| 31 | cn | German Shepherd | F | 9 y | tetraparesis, depression | necropsy |
| 32 | cn | Mixed breed | SF | 12 y | right hemiparesis | necropsy |
| 33 | cn | Dachshund | F | 2.5 y | depression, seizures | necropsy |
| 34 | cn | Boxer | F | 10.5 y | seizures | necropsy |
| 35 | cn | Mixed breed | F | 4 y | tetraplegia | necropsy |
| 36 | cn | Mixed breed | M | 14 y | left HL monoparesis | necropsy |
| 37 | cn | Mixed breed | M | 9 y | tetraparesis | necropsy |
| 38 | cn | German Shepherd | F | 3 y | paraparesis | necropsy |
| 39 | cn | Hound | F | 2 y | severe depression, tetraparesis | necropsy |
| 40 | cn | Boxer | F | 7 y | neck pain, intracranial syndrome | necropsy |
| 41 | cn | Mixed breed | M | 14 y | central vestibular syndrome | necropsy |
| 42 | cn | Amstaff | M | 3 y | right HL progressive lameness | biopsy |
| 43 | cn | Cane Corso | F | 7 y | monoplegia | biopsy |
| 44 | cn | Rottweiler | F | 4.5 y | right HL monoparesis | biopsy |
| 45 | cn | Labrador Retriever | M | 10 y | tetraparesis, paraplegia | biopsy |
| 46 | fn | ESH | F | 9 y | bilateral blindness, depression, seizures, | necropsy |
| 47 | fn | ESH | F | 5 y | ataxia, left HL monoparesis, strangury | biopsy |
| 48 | fn | Persian | M | 11 y | seizures, ataxia, blindness | necropsy |
| 49 | fn | ESH | M | 6 y | progressive paraparesis, ataxia | necropsy |
| 50 | fn | ESH | F | 14 y | ataxia, depression | necropsy |
| 51 | fn | ESH | M | 9 y | ataxia, depression, vertical nystagmus | biopsy |
| 52 | fn | ESH | NM | 14 y | depression, compulsive gait | necropsy |
| 53 | fn | ESH | M | 11 y | paraplegia | necropsy |
| 54 | fn | ESH | M | 8 y | forebrain syndrome | biopsy |
| 55 | fn | ESH | NM | 17 y | seizures, depression, tetraparesis, bilateral mydriasis | necropsy |
| 56 | fn | ESH | M | 8 y | left FL monoplegia and muscle atrophy | necropsy |
| 57 | fn | ESH | SF | 5 y | paraplegia | biopsy |
| 58 | fn | ESH | F | 12 y | forebrain syndrome | necropsy |
| 59 | fn | ESH | M | 3 y | paraplegia | necropsy |
| 60 | fn | ESH | M | 1 y | back pain, paraparesis | biopsy |
| 61 | fn | ESH | F | 10 y | prosencephalic syndrome | necropsy |
| 62 | fn | ESH | NM | 11 y | depression, right drifting, compulsive gait | biopsy |
| 63 | fn | ESH | NM | 12 y | compulsive gait, left circling | necropsy |
| 64 | fn | ESH | NM | 4 y | seizures | necropsy |
| 65 | fn | ESH | SF | 12 y | progressive tetraparesis | necropsy |
| 66 | fn | ESH | M | 11 y | left blindness, forebrain syndrome | necropsy |
| 67 | fn | ESH | M | 4 y | paraparesis | necropsy |
| 68 | fn | ESH | SF | 5 y | progressive paraparesis | biopsy |
| 69 | fn | ESH | SF | 15 y | blindness, forebrain syndrome | necropsy |
| 70 | fn | ESH | SF | 8 y | ataxia, behavioral changes, mydriasis, left |
necropsy |
| 71 | fn | ESH | NM | 9 y | brainstem syndrome | necropsy |
| 72 | fn | ESH | SF | 4 y | paraplegia | biopsy |
| 73 | fn | ESH | NM | 1 y | paraplegia, loss of deep pain sensation | biopsy |
| 74 | fn | Ragdoll | F | 3 m | seizures | necropsy |
| 75 | fn | ESH | SF | 3 y | paraplegia | necropsy |
| 76 | fn | ESH | M | 10 y | paraplegia, back pain | necropsy |
| 77 | fn | Maine Coon | F | 13 y | depression, paraparesis | necropsy |
| 78 | fn | ESH | SF | 8 m | paraparesis | biopsy |
| 79 | fn | ESH | M | 8 m | paraplegia, loss of deep pain sensation | necropsy |
| 80 | fn | Norwegian Forest cat | SF | 11 y | depression, weakness, ↓ left menace response and left pupillary light reflex | necropsy |
| 81 | fn | ESH | F | 12.5 y | left circling, anisocoria, left miosis, right FL monoparesis | necropsy |
| 82 | fn | Carthusian | M | 6 y | progressive paraparesis | necropsy |
| 83 | fn | ESH | SF | 10 y | paraparesis | necropsy |
| 84 | fn | ESH | F | 2 y | acute paraplegia | necropsy |
| 85 | fn | ESH | SF | 11 y | tetraparesis | necropsy |
| 86 | fn | Siamese | SF | 7 y | paraparesis, hyperesthesia, ↓ pain sensation, ataxia, urinary loss | necropsy |
| 87 | fn | ESH | F | 7 y | severe paraparesis | biopsy |
| 88 | fn | ESH | M | 14 y | right hemiparesis | necropsy |
| 89 | fn | ESH | SF | 7 y | acute tetraplegia, dysphagia, right Horner syndrome | necropsy |
| 90 | fn | ESH | M | 14 y | progressive tetraparesis | biopsy |
| 91 | fn | ELH | SF | 12 y | right HL monoplegia | biopsy |
| 92 | fn | ESH | SF | 11 y | lameness and monoparesis | biopsy |
cn = canine; fn = feline; ESH = European Shorthair cat; ELH = European Longhair cat; M = male; NM = neutered male; F = female; SF = spayed female; y = years; m = months; FL = forelimbs; HL = hindlimbs; ↓ = reduced.
Type, anatomical site, location, distribution, pathological pattern, nuclear size, grading, and phenotype of nervous system lymphoma in 92 canine and feline cases.
| N° | Species | Type | Anatomical Site | Location and Distribution | Pathological |
Nuclear Size | Grading | Phenotype |
|---|---|---|---|---|---|---|---|---|
| 1 | cn | II | IC | occipital lobe | IP | large | medium | B |
| 2 | cn | I | SC | T10-T13 | ED | intermed. | low | B |
| 3 | cn | II | SC | L3-L5 | ED | large | high | B |
| 4 | cn | II | IC | occipito-temporal lobe | IP, MM | large | high | T |
| 5 | cn | II | SC, PNS | cauda equina, sciatic nerve | IM, NL | small | low | B |
| 6 | cn | I | PNS | L6 nerve root | NL | large | high | B |
| 7 | cn | I | SC | T9 | ED | large | high | B |
| 8 | cn | II | IC | occipital lobe | IP | large | high | non-B, non-T |
| 9 | cn | II | SC, PNS | LS, sciatic nerves | IM, NL | large | high | T |
| 10 | cn | I | IC, PNS | parieto-occipital lobes, V nerve root | IP, NL | large | high | B |
| 11 | cn | II | IC | basal nuclei | IP | large | high | T |
| 12 | cn | II | PNS | ischiatic nerve | NL | large | high | B |
| 13 | cn | II | PNS | L1 nerve root | NL | large | high | B |
| 14 | cn | II | IC | occipital lobe | IP | large | high | B |
| 15 | cn | II | SC | L | ED | large | high | B |
| 16 | cn | II | SC | C3-C6 | ED | large | medium | B |
| 17 | cn | II | SC | T11-T13 | ED | small | low | T |
| 18 | cn | II | IC | thalamus, cerebellum, m. obl., CP, PG | IP, MM | large | high | B |
| 19 | cn | I | SC | T6-T7 | IM | large | high | non-B, non-T |
| 20 | cn | I | SC | C3-C4 | IM | intermed. | low | B |
| 21 | cn | I | IC, PNS | trigeminal nerves, CP | NL | intermed. | low | B |
| 22 | cn | I | SC | L4-L7 | ED | large | high | B |
| 23 | cn | II | SC | T12-L1 | ED | large | high | B |
| 24 | cn | I | IC | thalamus | IP | large | high | B |
| 25 | cn | I | IC | multifocal | IVL | large | ND | B |
| 26 | cn | I | IC | multifocal | IVL | large | ND | non-B, non-T |
| 27 | cn | I | IC | multifocal | IVL | large | ND | T |
| 28 | cn | I | IC | multifocal, CP | IVL | large | ND | non-B, non-T |
| 29 | cn | I | IC | multifocal | IVL | large | ND | B |
| 30 | cn | I | IC | multifocal, CP | IVL | large | ND | B |
| 31 | cn | I | IC | multifocal | IVL | large | ND | T |
| 32 | cn | II | IC | multifocal | IVL | large | ND | non-B, non-T |
| 33 | cn | I | IC | multifocal | IVL | large | ND | T |
| 34 | cn | I | IC | multifocal | IVL | large | ND | non-B, non-T |
| 35 | cn | II | SC | C, CT, TL, LS | ID-EM, LL | small | medium | B |
| 36 | cn | I | PNS | L femoral nerve | NL | large | high | T |
| 37 | cn | II | PNS | multiple spinal nerves | NL | intermed. | low | T |
| 38 | cn | II | SC | T | ED | small | medium | T |
| 39 | cn | I | IC | diffuse | LC | intermed. | medium | T |
| 40 | cn | II | IC | frontal, temporal, cerebellar lobes | LL | large | high | T |
| 41 | cn | II | IC | ponto-cerebellar angle | IP | large | high | B |
| 42 | cn | I | PNS | L5 nerve root | NL | large | low | B |
| 43 | cn | I | PNS | sciatic nerve | NL | large | low | T |
| 44 | cn | I | PNS | sciatic nerve | NL | large | medium | T |
| 45 | cn | I | PNS | sciatic nerves | NL | small | low | T |
| 46 | fn | I | IC | optic nerves, diencephalon | IP | intermed. | medium | B |
| 47 | fn | I | SC | L4-L5 | ED | intermed. | low | B |
| 48 | fn | II | IC | parietal lobe | IP | intermed. | medium | T |
| 49 | fn | II | IC, SC | cerebellar, T | LL, ED | large | medium | B |
| 50 | fn | I | IC | frontal lobe | IP, MM | large | high | non-B, non-T |
| 51 | fn | I | IC | frontal lobe | IP, MM | large | high | B |
| 52 | fn | II | IC | frontal lobe, CP | IP, MM | large | high | B |
| 53 | fn | II | SC | LS | ED | small | medium | T |
| 54 | fn | I | IC | parietal lobe | IP, MM | large | high | B |
| 55 | fn | I | IC | diencephalon, thalamus | IP, MM | small | low | T |
| 56 | fn | II | PNS | brachial plexus | NL | large | medium | T |
| 57 | fn | I | SC | T12-L1 | ED | small | low | B |
| 58 | fn | I | IC | frontal lobe, diencephalon | IP, MM | large | high | T |
| 59 | fn | I | SC | L5-L6 | ED | large | medium | B |
| 60 | fn | II | SC | L1 | ED | large | high | B |
| 61 | fn | II | IC | frontal lobe | MM | large | medium | non-B, non-T |
| 62 | fn | I | IC | frontal lobe | IP | intermed. | medium | T |
| 63 | fn | I | IC | frontal lobe | IP, MM | large | high | B |
| 64 | fn | I | IC | frontal lobe | IP, MM | large | high | B |
| 65 | fn | I | SC | CT | IM | large | high | non-B, non-T |
| 66 | fn | II | IC | diencephalon | IP, MM | intermed. | high | B |
| 67 | fn | II | SC | T8 | ED | large | high | B |
| 68 | fn | I | SC | L3 | ED | large | medium | B |
| 69 | fn | II | IC | diencephalon | IP, MM | large | high | B |
| 70 | fn | II | IC | medulla oblongata | IP | intermed. | low | B |
| 71 | fn | II | IC | medulla oblongata | IP | large | low | T |
| 72 | fn | I | SC | L3-L4 | ED | small | medium | B |
| 73 | fn | II | SC | T11 | ED | small | medium | T |
| 74 | fn | I | PNS | cervical spinal nerves | NL | large | low | B |
| 75 | fn | I | SC | TL | ED | small | low | T |
| 76 | fn | II | SC | TL | ID-EM | intermed. | low | T |
| 77 | fn | II | IC, SC | cerebral cortex, m. obl., T | ID-EM, MM | small | medium | T |
| 78 | fn | I | SC | T5-T7 | ED | intermed. | medium | B |
| 79 | fn | II | IC, SC | TL, CP | MM, ED | small | low | B |
| 80 | fn | I | IC | olfactory lobe | IP, MM | large | high | B |
| 81 | fn | I | IC | parietal lobe | IP, MM | intermed. | medium | T |
| 82 | fn | II | IC, PNS | C and TL nerve roots | NL | small | low | B |
| 83 | fn | II | SC | TL | ED | small | low | T |
| 84 | fn | II | SC | TL | ED | small | low | B |
| 85 | fn | II | SC | CT | ED | intermed. | medium | T |
| 86 | fn | I | SC | LS | ED | intermed. | low | non-B, non-T |
| 87 | fn | I | SC | T11-T12 | ID-EM | large | medium | T |
| 88 | fn | I | IC | forebrain, midbrain | LL | large | high | T |
| 89 | fn | I | IC, PNS | II, V cranial, brachial, sciatic nerves | NL | intermed. | low | B |
| 90 | fn | I | PNS | C7 nerve root | NL | small | low | T |
| 91 | fn | I | PNS | sciatic nerve | NL | small | medium | T |
| 92 | fn | I | PNS | sciatic nerve | NL | large | medium | B |
cn = canine; fn = feline; I = primary form; II = secondary/multicentric form; IC = intracranial; SC = intraspinal; PNS = peripheral nervous system; C = cervical; CT = cervicothoracic; T = thoracic; L = lumbar; TL = thoracolumbar; S = sacral spinal cord; CP = choroid plexus; PG = pituitary gland; IP = intraparenchymal mass; MM = meningeal mass; LL = leptomeningeal lymphomatosis; IVL = intravascular lymphoma; LC = lymphomatosis cerebri; ED = extradural; ID-EM = intradural-extramedullary; IM = intramedullary; NL = neurolymphomatosis, ND = not determined.
References
1. Snyder, J.M.; Shofer, F.S.; Van Winkle, T.J.; Massicotte, C. Canine intracranial primary neoplasia: 173 cases (1986–2003). J. Vet. Intern. Med.; 2006; 20, pp. 669-675. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16734106]
2. Rissi, D.R.; McHale, B.J.; Miller, A.D. Primary nervous system lymphoma in cats. J. Vet. Diagn. Investig.; 2022; 34, pp. 712-717. [DOI: https://dx.doi.org/10.1177/10406387221090281]
3. Snyder, J.; Lipitz, L.; Skorupski, K.; Shofer, F.; Van Winkle, T. Secondary intracranial neoplasia in the dog: 177 cases (1986–2003). J. Vet. Intern. Med.; 2008; 22, pp. 172-177. [DOI: https://dx.doi.org/10.1111/j.1939-1676.2007.0002.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18289306]
4. Kishimoto, T.E.; Uchida, K.; Chambers, J.K.; Kok, M.K.; Son, N.V.; Shiga, T.; Hirabayashi, M.; Ushio, N.; Nakayama, H. A retrospective survey on canine intracranial tumors between 2007 and 2017. J. Vet. Med. Sci.; 2020; 82, pp. 77-83. [DOI: https://dx.doi.org/10.1292/jvms.19-0486] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31801930]
5. Troxel, M.T.; Vite, C.H.; Winkle, T.J.; Newton, A.L.; Tiches, D.; Dayrell-Hart, B.; Kapatkin, A.S.; Shofer, F.S.; Steinberg, S.A. Feline intracranial neoplasia: Retrospective review of 160 cases (1985–2001). J. Vet. Intern. Med.; 2003; 17, pp. 850-859.
6. Song, R.; Vite, C.; Bradley, C.; Cross, J. Postmortem evaluation of 435 cases of intracranial neoplasia in dogs and relationship of neoplasm with breed, age, and body weight. J. Vet. Intern. Med.; 2013; 27, pp. 1143-1152. [DOI: https://dx.doi.org/10.1111/jvim.12136]
7. Marioni-Henry, K.; Van Winkle, T.J.; Smith, S.H.; Vite, C.H. Tumors affecting the spinal cord of cats: 85 cases (1980–2005). J. Am. Vet. Med. Assoc.; 2008; 232, pp. 237-243. [DOI: https://dx.doi.org/10.2460/javma.232.2.237]
8. Mandara, M.T.; Domini, A.; Giglia, G. Feline lymphoma of the nervous system. Immunophenotype and anatomical patterns in 24 cases. Front. Vet. Sci.; 2022; 9, 959466. [DOI: https://dx.doi.org/10.3389/fvets.2022.959466] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36157173]
9. Pfaff, A.M.; March, P.A.; Fishman, C. Acute bilateral trigeminal neuropathy associated with nervous system lymphosarcoma in a dog. J. Am. Anim. Hosp. Assoc.; 2000; 36, pp. 57-61. [DOI: https://dx.doi.org/10.5326/15473317-36-1-57] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10667407]
10. Schaffer, P.A.; Charles, J.B.; Tzipory, L.; Ficociello, J.E.; Marvel, S.J.; Barrera, J.; Spraker, T.R.; Ehrhart, E.J. Neurolymphomatosis in a dog with B-cell lymphoma. Vet. Pathol.; 2012; 49, pp. 771-774. [DOI: https://dx.doi.org/10.1177/0300985811419531]
11. Rupp, A.; Ives, E.; Rudorf, H.; Constantino-Casas, F. Sciatic T-cell neurolymphomatosis in a dog. Vet. Rec. Case Rep.; 2014; 2, e000050. [DOI: https://dx.doi.org/10.1136/vetreccr-2014-000050]
12. Ueno, H.; Miyoshi, K.; Fukui, S.; Kondo, Y.; Matsuda, K.; Uchide, T. Extranodal lymphoma with peripheral nervous system involvement in a dog. J. Vet. Med. Sci.; 2014; 76, pp. 723-727. [DOI: https://dx.doi.org/10.1292/jvms.13-0159] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24419974]
13. Nakagun, S.; Horiuchi, N.; Watanabe, K.; Matsumoto, K.; Tagawa, M.; Shimbo, G.; Kobayashi, Y. CD3 and CD20 co-expression in a case of canine peripheral T-cell lymphoma with prominent cardiac and peripheral nerve involvement. J. Vet. Diagn. Investig.; 2018; 30, pp. 779-783. [DOI: https://dx.doi.org/10.1177/1040638718794765] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30129396]
14. Lane, S.B.; Kornegay, J.N.; Duncan, J.R.; Oliver, J.E., Jr. Feline spinal lymphosarcoma: A retrospective evaluation of 23 cats. J. Vet. Intern. Med.; 1994; 8, pp. 99-104. [DOI: https://dx.doi.org/10.1111/j.1939-1676.1994.tb03205.x]
15. Higgins, M.A.; Rossmeisl, J.H.; Saunders, G.K.; Hayes, S.; Kiupel, M. B-cell lymphoma in the peripheral nerves of a cat. Vet. Pathol.; 2008; 45, pp. 54-57. [DOI: https://dx.doi.org/10.1354/vp.45-1-54] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18192576]
16. Linzmann, H.; Brunnberg, L.; Gruber, A.D.; Klopfleisch, R. A neurotropic lymphoma in the brachial plexus of a cat. J. Feline Med. Surg.; 2009; 11, pp. 522-524. [DOI: https://dx.doi.org/10.1016/j.jfms.2008.09.007]
17. Bray, K.Y.; Muñana, K.R.; Meichner, K.; White, L.A.; Seiler, G. Eosinophilic meningomyelitis associated with T-cell lymphoma in a cat. Vet. Clin. Pathol.; 2016; 45, pp. 698-702. [DOI: https://dx.doi.org/10.1111/vcp.12406]
18. Mello, L.S.; Leite-Filho, R.V.; Panziera, W.; Bandinelli, M.B.; Sonne, L.; Driemeier, D.; Pavarini, S.P. Feline lymphoma in the nervous system: Pathological, immunohistochemical, and etiological aspects in 16 cats. Pes. Vet. Bras.; 2019; 39, pp. 393-401. [DOI: https://dx.doi.org/10.1590/1678-5150-pvb-6295]
19. LeCouteur, R.A. Update on feline neuromuscular diseases. J. Feline Med. Surg.; 2003; 5, pp. 109-115. [DOI: https://dx.doi.org/10.1016/S1098-612X(02)00125-0]
20. LaRue, M.K.; Taylor, A.; Back, A.R.; Lindley, S.E.; Boudreaux, B.L.; Almond, G.T.; Shores, A.; Brawner, W.R.; Smith, A.N. Central nervous system lymphoma in 18 dogs (2001 to 2015). J. Small Anim. Pract.; 2018; 59, pp. 547-552. [DOI: https://dx.doi.org/10.1111/jsap.12868] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30022475]
21. Durand, A.; Keenihan, E.; Schweizer, D.; Maiolini, A.; Guevar, J.; Oevermann, A.; Gutierrez-Quintana, R. Clinical and mag-netic resonance imaging features of lymphoma involving the nervous system in cats. J. Vet. Intern. Med.; 2022; 36, pp. 679-693. [DOI: https://dx.doi.org/10.1111/jvim.16350]
22. Rosin, A. Neurologic diseases associated with lymphosarcoma in ten dogs. J. Am. Vet. Med. Assoc.; 1982; 181, pp. 50-53.
23. Britt, J.O., Jr.; Simpson, J.G.; Howard, E.B. Malignant lymphoma of the meninges in two dogs. J. Comp. Pathol.; 1984; 94, pp. 45-53. [DOI: https://dx.doi.org/10.1016/0021-9975(84)90007-0]
24. Vernau, K.M.; Higgins, R.J.; Bollen, A.W.; Jimenez, D.F.; Anderson, J.V.; Koblik, P.D.; Lecouteur, R.A. Primary canine and feline nervous system tumors: Intraoperative diagnosis using the smear technique. Vet. Pathol.; 2001; 38, pp. 47-57. [DOI: https://dx.doi.org/10.1354/vp.38-1-47] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11199164]
25. Kim, N.-H.; Ciesielski, T.; Kim, J.H.; Yhee, J.-Y.; Im, K.-S.; Nam, H.-M.; Kim, I.-H.; Kim, J.-H.; Sur, J.-H. Primary central nervous system B-cell lymphoma in a young dog. Am. Jew. Hist.; 2012; 53, pp. 559-564.
26. Sisó, S.; Marco-Salazar, P.; Moore, P.F.; Sturges, B.K.; Vernau, W.; Wisner, E.R.; Bollen, A.W.; Dickinson, P.J.; Higgins, R.J. Canine nervous system lymphoma subtypes display characteristic neuroanatomical patterns. Vet. Pathol.; 2016; 54, pp. 53-60. [DOI: https://dx.doi.org/10.1177/0300985816658101]
27. Lampe, R.; Levitin, H.A.; Hecht, S.; Vieson, M.D.; Selting, K.A.; Hague, D.W.; Foss, K.D. MRI of CNS lymphoma with choroid plexus involvement in five dogs and one cat. J. Small Anim. Pract.; 2021; 62, pp. 690-699. [DOI: https://dx.doi.org/10.1111/jsap.13324] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33769594]
28. Czasch, S.; Risse, K.; Baumgärtner, W. Central nervous system metastasis of a cutaneous epitheliotropic lymphosarcoma in a dog. J. Comp. Pathol.; 2000; 123, pp. 59-63. [DOI: https://dx.doi.org/10.1053/jcpa.1999.0382]
29. Kent, M.; Delahunta, A.; Tidwell, A.S. MR imaging findings in a dog with intravascular lymphoma in the brain. Vet. Radiol. Ultrasound; 2001; 42, pp. 504-510. [DOI: https://dx.doi.org/10.1111/j.1740-8261.2001.tb00977.x]
30. Long, S.N.; Johnston, P.E.J.; Anderson, T.J. Primary T-cell lymphoma of the central nervous system in a dog. J. Am. Vet. Med. Assoc.; 2001; 218, pp. 719-722. [DOI: https://dx.doi.org/10.2460/javma.2001.218.719]
31. Thomovsky, S.A.; Packer, R.A.; Burcham, G.N.; Heng, H.G. Imaging diagnosis-magnetic resonance imaging features of met-astatic cerebral lymphoma in a dog. Vet. Radiol. Ultrasound.; 2011; 52, pp. 192-195. [DOI: https://dx.doi.org/10.1111/j.1740-8261.2010.01768.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21388473]
32. Ortega, M.; Castillo-Alcala, F. Hind-limb paresis in a dog with paralumbar solitary T-cell lymphoma. Am. Jew. Hist.; 2010; 51, pp. 480-484.
33. Veraa, S.; Dijkman, R.; Meij, B.P.; Voorhout, G. Comparative imaging of spinal extradural lymphoma in a Bordeaux dog. Am. Jew. Hist.; 2010; 51, pp. 519-521.
34. Mattei, C.; Oevermann, A.; Schweizer, D.; Guevar, J.; Maddox, T.W.; Fleming, K.L.; Ricci, E.; Rosati, M.; Biserni, R.; Iv, J.F.G. et al. MRI ischemic and hemorrhagic lesions in arterial and venous territories characterize central nervous system intravascular lymphoma in dogs. Vet. Radiol. Ultrasound; 2022; [DOI: https://dx.doi.org/10.1111/vru.13165] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36329600]
35. Morrison, J.A.; Fales-Williams, A. Hypernatremia associated with intracranial B-cell lymphoma in a cat. Vet. Clin. Pathol.; 2006; 35, pp. 362-365. [DOI: https://dx.doi.org/10.1111/j.1939-165X.2006.tb00150.x]
36. Nakamoto, Y.; Ozawa, T.; Uchida, K.; Omori, K.; Hase, K.; Nakaichi, M. Primary Intra-Axial B-Cell Lymphoma in a Cat. J. Vet. Med. Sci.; 2009; 71, pp. 207-210. [DOI: https://dx.doi.org/10.1292/jvms.71.207] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19262034]
37. Simpson, C.J.; Mansfield, C.S.; Milne, M.E.; Hodge, P.J. Central diabetes insipidus in a cat with central nervous system B cell lymphoma. J. Feline Med. Surg.; 2011; 13, pp. 787-792. [DOI: https://dx.doi.org/10.1016/j.jfms.2011.07.005] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21906986]
38. Tanaka, T.; Akiyoshi, H.; Shimazaki, H.; Kawakami, R.; Mie, K.; Yamada, Y.; Ohashi, F. Apparent diffusion coefficient value for a B-cell central nervous system lymphoma in a cat. J. Feline Med. Surg. Open Rep.; 2018; 4, 2055116917750762. [DOI: https://dx.doi.org/10.1177/2055116917750762]
39. Leite-Filho, R.V.; Panziera, W.; Bandinelli, M.B.; Henker, L.C.; Monteiro, K.C.; Corbellini, L.G.; Driemeier, D.; Sonne, L.; Pavarini, S.P. Epidemiological, pathological and immunohistochemical aspects of 125 cases of feline lymphoma in Southern Brazil. Vet. Comp. Oncol.; 2019; 18, pp. 224-230. [DOI: https://dx.doi.org/10.1111/vco.12535]
40. Pardo, A.P.; Gómez, M.A.; González, C.M. Cerebellar cortical degeneration associated with feline leukemia virus infection and cerebellar lymphoma in a young cat. Open Vet. J.; 2019; 9, pp. 246-252. [DOI: https://dx.doi.org/10.4314/ovj.v9i3.9]
41. Fondevila, D.; Vilafranca, M.; Pumarola, M. Primary central nervous system T-cell lymphoma in a cat. Vet. Pathol.; 1998; 35, pp. 550-553. [DOI: https://dx.doi.org/10.1177/030098589803500613]
42. Morita, T.; Kondo, H.; Okamoto, M.; Park, C.; Sawashima, Y.; Shimada, A. Periventricular spread of primary central nervous system T-cell lymphoma in a cat. J. Comp. Pathol.; 2008; 140, pp. 54-58. [DOI: https://dx.doi.org/10.1016/j.jcpa.2008.09.003]
43. Tsuboi, M.; Uchida, K.; Park, E.S.; Kotera, Y.; Seki, T.; Takahashi, M.; Nakayama, H. Systemic T-cell large granular lymphocyte lymphoma with multifocal white matter degeneration in the brain of a Japanese domestic cat. J. Vet. Med. Sci.; 2010; 72, pp. 795-799. [DOI: https://dx.doi.org/10.1292/jvms.09-0525]
44. Valli, V.E.; Myint, M.S.; Barthel, A.; Bienzle, D.; Caswell, J.; Colbatzky, F.; Durham, A.; Ehrhart, E.J.; Johnson, Y.; Jones, C. et al. Classification of canine malignant lymphomas according to the World Health Organization criteria. Vet. Pathol.; 2010; 48, pp. 198-211. [DOI: https://dx.doi.org/10.1177/0300985810379428]
45. Degl’Innocenti, S.; Della Camera, N.; Falzone, C.; Cantile, C. Canine cerebral intravascular lymphoma: Neuropathological and immunohistochemical findings. Vet. Pathol.; 2018; 56, pp. 239-243. [DOI: https://dx.doi.org/10.1177/0300985818806059] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30286705]
46. Callanan, J.; Jones, B.A.; Irvine, J.; Willett, B.J.; McCandlish, I.A.P.; Jarrett, O. Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections. Vet. Pathol.; 1996; 33, pp. 264-272. [DOI: https://dx.doi.org/10.1177/030098589603300302] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8740699]
47. Tomek, A.; Cizinauskas, S.; Doherr, M.; Gandini, G.; Jaggy, A. Intracranial neoplasia in 61 cats: Localisation, tumour types and seizure patterns. J. Feline Med. Surg.; 2006; 8, pp. 243-253. [DOI: https://dx.doi.org/10.1016/j.jfms.2006.01.005] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16600653]
48. Palus, V.; Volk, H.A.; Lamb, C.R.; Targett, M.P.; Cherubini, G.B. MRI features of cns lymphoma in dogs and cats. Vet. Radiol. Ultrasound; 2011; 53, pp. 44-49. [DOI: https://dx.doi.org/10.1111/j.1740-8261.2011.01872.x]
49. Mandara, M.T.; Motta, L.; Calò, P. Distribution of feline lymphoma in the central and peripheral nervous systems. Vet. J.; 2016; 216, pp. 109-116. [DOI: https://dx.doi.org/10.1016/j.tvjl.2016.07.013]
50. Yoshino, Y.; Chambers, J.K.; Nakamori, T.; Goto-Koshino, Y.; Nishigaki, K.; Tsujimoto, H.; Matsuki, N.; Nakayama, H.; Uchida, K. Primary cerebellar lymphoma with Hodgkin lymphoma–like morphology in a cat. J. Vet. Diagn. Investig.; 2017; 29, pp. 707-710. [DOI: https://dx.doi.org/10.1177/1040638717704239]
51. Vail, D.M.; Withrow, S.; Page, R. Feline lymphoma and leukemia. Withrow and MacEwen’s Small Animal Clinical Oncology; 6th ed. Vail, D.M. Saunders Elsevier: St. Louis, MO, USA, 2020; pp. 715-730.
52. Yu, H.; Gao, B.; Liu, J.; Yu, Y.-C.; Shiroishi, M.S.; Huang, M.-M.; Yang, W.-X.; Guan, Z.-Z. Lymphomatosis cerebri: A rare variant of primary central nervous system lymphoma and MR imaging features. Cancer Imaging; 2017; 17, pp. 1-9. [DOI: https://dx.doi.org/10.1186/s40644-017-0128-2] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28982392]
53. Rollins, K.E.; Kleinschmidt-DeMasters, B.; Corboy, J.R.; Damek, D.M.; Filley, C.M. Lymphomatosis cerebri as a cause of white matter dementia. Hum. Pathol.; 2005; 36, pp. 282-290. [DOI: https://dx.doi.org/10.1016/j.humpath.2005.01.014] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15791573]
54. Luna, S.G.; Carrasco, L.; Gómez-Laguna, J.; Hilbe, M.; Mínguez, J.J.; Köhler, K.; Mulas, J.M.D.L. Primary central nervous system T-cell lymphoma mimicking meningoencephalomyelitis in a cat. Can. Vet. J.; 2013; 54, pp. 602-605.
55. Bakshi, R.; Mazziotta, J.C.; Mischel, P.S.; Jahan, R.; Seligson, D.B.; Vinters, H.V. Lymphomatosis cerebri presenting as a rapidly progressive dementia: Clinical, neuroimaging and pathologic findings. Dement. Geriatr. Cogn. Disord.; 1999; 10, pp. 152-157. [DOI: https://dx.doi.org/10.1159/000017116] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10026390]
56. Izquierdo, C.; Velasco, R.; Vidal, N.; Sánchez, J.J.; Argyriou, A.A.; Besora, S.; Graus, F.; Bruna, J. Lymphomatosis cerebri: A rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature. Neuro Oncol.; 2015; 18, pp. 707-715. [DOI: https://dx.doi.org/10.1093/neuonc/nov197]
57. Pfleger, L.; Tappeiner, J. Zur Kenntnis der systemisierten Endotheliomastose der cutanen Blutgefdsse. Hautzarzt; 1959; 10, pp. 359-363.
58. Ponzoni, M.; Campo, E.; Nakamura, S. Intravascular large B-cell lymphoma: A chameleon with multiple faces and many masks. Blood; 2018; 132, pp. 1561-1567. [DOI: https://dx.doi.org/10.1182/blood-2017-04-737445]
59. McDonough, S.P.; Van Winkle, T.J.; Valentine, B.A.; van Gessel, Y.A.; Summers, B.A. Clinicopathological and immunophenotypical features of canine intravascular lymphoma (malignant angioendotheliomatosis). J. Comp. Pathol.; 2002; 126, pp. 277-288. [DOI: https://dx.doi.org/10.1053/jcpa.2002.0553]
60. Ródenas, S.; Pumarola, M.; Gaitero, L.; Zamora, À.; Añor, S. Magnetic resonance imaging findings in 40 dogs with histologically confirmed intracranial tumours. Vet. J.; 2011; 187, pp. 85-91. [DOI: https://dx.doi.org/10.1016/j.tvjl.2009.10.011]
61. Henrich, M.; Huisinga, M.; Bauer, N.; Reinacher, M. A case of intravascular lymphoma with mixed lineage antigen expression in a cat. J. Vet. Med. Ser. A; 2007; 54, pp. 575-578. [DOI: https://dx.doi.org/10.1111/j.1439-0442.2007.01000.x]
62. Guillén, A.; Rossanese, M.; Ricci, E.; German, A.J.; Blackwood, L. Gastric intravascular lymphoma in a dog: Case report and literature review. J. Am. Anim. Hosp. Assoc.; 2020; 56, 185. [DOI: https://dx.doi.org/10.5326/JAAHA-MS-6994] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32182111]
63. Bush, W.W.; Throop, J.L.; McManus, P.M.; Kapatkin, A.S.; Vite, C.H.; Van Winkle, T.J. Intravascular lymphoma involving the central and peripheral nervous systems in a dog. J. Am. Anim. Hosp. Assoc.; 2003; 39, pp. 90-96. [DOI: https://dx.doi.org/10.5326/0390090] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12549621]
64. Steinberg, H. Multisystem angiotropic lymphoma (malignant angioendotheliomatosis) involving the humerus in a dog. J. Vet. Diagn. Investig.; 1996; 8, pp. 502-505. [DOI: https://dx.doi.org/10.1177/104063879600800422]
65. Lane, L.V.; Allison, R.W.; Rizzi, T.R.; Stern, A.W.; Snider, T.; Moore, P.F.; Vernau, W. Canine intravascular lymphoma with overt leukemia. Vet. Clin. Pathol.; 2012; 41, pp. 84-91. [DOI: https://dx.doi.org/10.1111/j.1939-165X.2011.00399.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22260096]
66. Zanoguera, V.L.; Motta, L. Multicentric intravascular lymphoma with particular involvement of the cervical spinal cord in a dog. J. Small Anim. Pract.; 2022; 63, 82. [DOI: https://dx.doi.org/10.1111/jsap.13424] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34523129]
67. Lapointe, J.M.; Higgins, R.J.; Kortz, G.D.; Bailey, C.S.; Moore, P.F. Intravascular malignant T-cell lymphoma (malignant angi-oendotheliomatosis) in a cat. Vet. Pathol.; 1997; 34, pp. 247-250. [DOI: https://dx.doi.org/10.1177/030098589703400314] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9163885]
68. Zaki, F.A.; Hurvitz, A.I. Spontaneous neoplasms of the central nervous system of the cat. J. Small Anim. Pract.; 1976; 17, pp. 773-782. [DOI: https://dx.doi.org/10.1111/j.1748-5827.1976.tb06943.x]
69. Pavlou, G.; Pal, D.; Bucur, S.; Chakrabarty, A.; Van Hille, P.T. Intracranial Non-Hodgkin’s MALT lymphoma mimicking a large convexity meningioma. Acta Neurochir.; 2006; 148, pp. 791-793. [DOI: https://dx.doi.org/10.1007/s00701-006-0761-1]
70. Matmati, K.S.; Matmati, N.; Hannun, Y.A.; Rumboldt, Z.; Patel, S.; Lazarchick, J.; Stuart, R.; Giglio, P. Dural MALT lymphoma with disseminated disease. Hematol. Rep.; 2010; 2, e10. [DOI: https://dx.doi.org/10.4081/hr.2010.e10]
71. Green, K.; Hogg, J.P. Central Nervous System Lymphoma. StatPearls [Internet]. Treasure Island (FL); StatPearls Publishing: Tampa, Fl, USA, 2022.
72. Mandara, M.T.; Rossi, F.; Lepri, E.; Angeli, G. Cerebellar leptomeningeal carcinomatosis in a dog. J. Small Anim. Pract.; 2007; 48, pp. 504-507. [DOI: https://dx.doi.org/10.1111/j.1748-5827.2007.00339.x]
73. Giordano, C.; Giudice, C.; Bellino, C.; Borrelli, A.; D’Angelo, A.; Gianella, P. A case of oculo-cerebral B-cell lymphoma in a cat. Vet. Ophthalmol.; 2012; 16, pp. 77-81. [DOI: https://dx.doi.org/10.1111/j.1463-5224.2012.01025.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22520020]
74. Grossman, S.A.; Krabak, M.J. Leptomeningeal carcinomatosis. Cancer Treat. Rev.; 1999; 25, pp. 103-119. [DOI: https://dx.doi.org/10.1053/ctrv.1999.0119]
75. Dallman, M.J.; Saunders, G.K. Primary spinal cord lymphosarcoma in a dog. J. Am. Vet. Med. Assoc.; 1986; 189, pp. 1348-1349.
76. Waters, D.J.; Hayden, D.W. Intramedullary spinal cord metastasis in the dog. J. Vet. Intern. Med.; 1990; 4, pp. 207-215. [DOI: https://dx.doi.org/10.1111/j.1939-1676.1990.tb00899.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2401967]
77. Spodnick, G.J.; Berg, J.; Moore, F.M.; Cotter, S.M. Spinal lymphoma in cats: 21 cases (1976–1989). J. Am. Vet. Med. Assoc.; 1992; 200, pp. 373-376.
78. Bagley, R.S.; Wheeler, S.J.; Klopp, L.; Sorjonen, D.C.; Thomas, W.B.; Wilkens, B.E.; Gavin, P.R.; Dennis, R. Clinical features of trigeminal nerve-sheath tumor in 10 dogs. J. Am. Anim. Hosp. Assoc.; 1998; 34, pp. 19-25. [DOI: https://dx.doi.org/10.5326/15473317-34-1-19]
79. Auger, M.; Hecht, S.; Springer, C.M. Magnetic resonance imaging features of extradural spinal neoplasia in 60 dogs and seven cats. Front. Vet. Sci.; 2021; 7, 610490. [DOI: https://dx.doi.org/10.3389/fvets.2020.610490]
80. Turner, J.L.; Luttgen, P.J.; VanGundy, T.E.; Roenigk, W.J.; Hightower, D.; Frelier, P.F. Multicentric osseous lymphoma with spinal extradural involvement in a dog. J. Am. Vet. Med. Assoc.; 1992; 200, pp. 196-198.
81. Lamagna, B.; Lamagna, F.; Meomartino, L.; Paciello, O.; Fatone, G. Polyostotic lymphoma with vertebral involvement and spinal extradural compression in a dog. J. Am. Anim. Hosp. Assoc.; 2006; 42, pp. 71-76. [DOI: https://dx.doi.org/10.5326/0420071]
82. Cho, J.-H.; Cho, D.-C.; Sung, J.-K.; Kim, K.-T. Primary malignant lymphoma in a spinal cord presenting as an epidural mass with myelopathy: A case report. Korean J. Spine; 2012; 9, pp. 265-268. [DOI: https://dx.doi.org/10.14245/kjs.2012.9.3.265]
83. Maccauro, G.; Spinelli, M.S.; Mauro, S.; Perisano, C.; Graci, C.; Rosa, M.A. Physiopathology of Spine Metastasis. Int. J. Surg. Oncol.; 2011; 2011, 107969. [DOI: https://dx.doi.org/10.1155/2011/107969] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22312491]
84. Wright, J.A. The pathological features associated with spinal tumours in 29 dogs. J. Comp. Pathol.; 1985; 95, pp. 549-557. [DOI: https://dx.doi.org/10.1016/0021-9975(85)90024-6]
85. Kippenes, H.; Gavin, P.R.; Bagley, R.S.; Silver, G.M.; Tucker, R.L.; Sande, R.D. Magnetic resonance imaging features of tumors of the spine and spinal cord in dogs. Vet. Radiol. Ultrasound; 1999; 40, pp. 627-633. [DOI: https://dx.doi.org/10.1111/j.1740-8261.1999.tb00890.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10608691]
86. Allett, B.; Hecht, S. Magnetic resonance imaging findings in the spine of six dogs diagnosed with lymphoma. Vet. Radiol. Ultrasound; 2016; 57, pp. 154-161. [DOI: https://dx.doi.org/10.1111/vru.12340]
87. Marioni-Henry, K.; Vite, C.H.; Newton, A.L.; Van Winkle, T.J. Prevalence of diseases of the spinal cord of cats. J. Vet. Intern. Med.; 2005; 18, pp. 851-858. [DOI: https://dx.doi.org/10.1111/j.1939-1676.2004.tb02632.x]
88. Bradshaw, J.; Pearson, G.; Gruffydd-Jones, T. A retrospective study of 286 cases of neurological disorders of the cat. J. Comp. Pathol.; 2004; 131, pp. 112-120. [DOI: https://dx.doi.org/10.1016/j.jcpa.2004.01.010]
89. Northington, J.W.; Juliana, M.M. Extradural lymphosarcoma in six cats. J. Small Anim. Pract.; 1978; 19, pp. 409-416. [DOI: https://dx.doi.org/10.1111/j.1748-5827.1978.tb05515.x]
90. Flatland, B.; Fry, M.M.; Newman, S.J.; Moore, P.F.; Smith, J.R.; Thomas, W.B.; Casimir, R.H. Large anaplastic spinal B-cell lymphoma in a cat. Vet. Clin. Pathol.; 2008; 37, pp. 389-396. [DOI: https://dx.doi.org/10.1111/j.1939-165X.2008.00049.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19055573]
91. Laisse, C.J.M.; Oliveira, E.C.; Rolim, V.M.; Negreiros, D.O.; Driemeier, D.; Pavarini, S.P. Hemorrhagic myelomalacia in a cat with extradural T-cell lymphoma. Semin. Ciências Agrárias; 2017; 38, pp. 327-334. [DOI: https://dx.doi.org/10.5433/1679-0359.2017v38n1p327]
92. De Lahunta, A.; Glass, E. Small animal spinal cord diseases. Veterinary Neuroanatomy and Clinical Neurology; 3rd ed. Saunders, W.B. Elsevier: St Louis, MO, USA, 2009; pp. 243-284.
93. Vail, D.M.; Pinkerton, M.; Young, K.M. Canine lymphoma and lymphocytic leukemia. Withrow and MacEwen’s Small Animal Clinical Oncology; 6th ed. Vail, D.M. Saunders Elsevier: St. Louis, MO, USA, 2020; pp. 688-715.
94. Brehm, D.M.; Vite, C.H.; Steinberg, H.S.; Haviland, J.; Van Winkle, T. A retrospective evaluation of 51 cases of peripheral nerve sheath tumors in the dog. J. Am. Anim. Hosp. Assoc.; 1995; 31, pp. 349-359. [DOI: https://dx.doi.org/10.5326/15473317-31-4-349]
95. Chijiwa, K.; Uchida, K.; Tateyama, S. Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas. Vet. Pathol.; 2004; 41, pp. 307-318. [DOI: https://dx.doi.org/10.1354/vp.41-4-307]
96. Schulman, F.Y.; Johnson, T.O.; Facemire, P.R.; Fanburg-Smith, J.C. Feline peripheral nerve sheath tumors: Histologic, im-munohistochemical, and clinicopathologic correlation (59 tumors in 53 cats). Vet. Pathol.; 2009; 46, pp. 1166-1180. [DOI: https://dx.doi.org/10.1354/vp.08-VP-0327-S-FL] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19605904]
97. Luttgen, P.J.; Braund, K.G.; Brawner, W.R.; Vandevelde, M. A retrospective study of twenty-nine spinal tumours in the dog and cat. J. Small Anim. Pract.; 1980; 21, pp. 213-226. [DOI: https://dx.doi.org/10.1111/j.1748-5827.1980.tb01238.x]
98. Fankhauser, R.; Vandevelde, M. Zur klinik der tumoren des Nervensystems bei Hund und Katze. Schweiz Arch Tierheilkd; 1981; 123, 553.
99. Bradley, R.L.; Withrow, S.J.; Snyder, S.P. Nerve sheath tumors in the dog. J. Am. Anim. Hosp. Assoc.; 1982; 18, 915.
100. Fox, J.G.; Gutnick, M.J. Horner’s syndrome and brachial paralysis due to lymphosarcoma in a cat. J. Am. Vet. Med. Assoc.; 1972; 160, pp. 977-980.
101. Allen, J.G.; Amis, T. Lymphosarcoma involving cranial nerves in a cat. Aust. Vet. J.; 1975; 51, pp. 155-158. [DOI: https://dx.doi.org/10.1111/j.1751-0813.1975.tb09443.x]
102. Hughes, R.A.C.; Britton, T.; Richards, M. Effects of lymphoma on the peripheral nervous system. J. R. Soc. Med.; 1994; 87, pp. 526-530. [DOI: https://dx.doi.org/10.1177/014107689408700915]
103. Mandrioli, L.; Morini, M.; Biserni, R.; Gentilini, F.; Turba, M.E. A case of feline neurolymphomatosis: Pathological and molecular investigations. J. Vet. Diagn. Investig.; 2012; 24, pp. 1083-1086. [DOI: https://dx.doi.org/10.1177/1040638712460674]
104. Del Grande, A.; Sabatelli, M.; Luigetti, M.; Conte, A.; Granata, G.; Rufini, V.; Del Ciello, A.; Gaudino, S.; Fernández, E.; Hohaus, S. et al. Primary multifocal lymphoma of peripheral nervous system: Case report and review of the literature. Muscle Nerve; 2014; 50, pp. 1016-1022. [DOI: https://dx.doi.org/10.1002/mus.24354]
105. Mori, M.; Izawa, T.; Sasaki, H.; Sonoyama, J.; Nishimura, S.; Shimamura, S.; Shimada, T.; Hasegawa, T.; Kuwamura, M.; Yamate, J. A case of feline T-cell lymphoma with tropism for striated muscle and peripheral nerve. J. Comp. Pathol.; 2019; 168, pp. 8-12. [DOI: https://dx.doi.org/10.1016/j.jcpa.2019.02.002]
106. Henke, D.; Vandevelde, M.; Oevermann, A. Polyganglioradiculoneuritis in a young cat: Clinical and histopathological findings. J. Small Anim. Pract.; 2009; 50, pp. 246-250. [DOI: https://dx.doi.org/10.1111/j.1748-5827.2009.00703.x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19425174]
107. Mellanby, R.J.; Jeffery, N.D.; Baines, E.A.; Woodger, N.; Herrtage, M.E. Magnetic resonance imaging in the diagnosis of lym-phoma involving the brachial plexus in a cat. Vet. Radiol. Ultrasound; 2003; 44, pp. 522-525. [DOI: https://dx.doi.org/10.1111/j.1740-8261.2003.tb00500.x]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Simple Summary
Nervous system lymphoma (NSL) is reported to be uncommon in dogs and rare in cats. The literature on this topic is fragmentary with heterogeneous results. Current knowledge is based on a few case series and mostly on single case reports. Therefore, the aim of our study was to retrospectively analyze 92 cases of canine and feline NSL, collecting data on breed, age, gender, clinical signs, type, neurolocalization, and assessing pathological patterns and phenotype. Finally, our results were compared with previously published studies and an extensive review of the literature was provided.
AbstractThe literature about nervous system lymphoma (NSL) in dogs and cats is fragmentary, based on a few case series and case reports with heterogeneous results. The aim of our study was to retrospectively analyze 45 cases of canine and 47 cases of feline NSL and compare our results with previously reported data, also providing an extensive literature review. Breed, age, gender, clinical signs, type, and neurolocalization were recorded for each case. The pathological patterns and phenotype were assessed by histopathology and immunohistochemistry. The occurrence of central and peripheral NSL was similar between the two species in both primary and secondary types. NSL occurred with a slightly higher prevalence in Labrador Retrievers, and spinal cord lymphoma (SCL) was associated with young age in cats. The most frequent locations were the forebrain in dogs and the thoracolumbar segment in cats. Primary central nervous system lymphoma (CNSL) in cats most frequently involved the forebrain meninges, particularly as a B-cell phenotype. Peripheral NSL mostly affected the sciatic nerve in dogs and had no preferred location in cats. Nine different pathological patterns were identified, with extradural as the most prevalent SCL pattern in both species. Finally, lymphomatosis cerebri was described for the first time in a dog.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Parisi, Francesca 1
; Aytaş, Çağla 1 ; Sara Degl’Innocenti 2
; Cantile, Carlo 1
1 Department of Veterinary Sciences, University of Pisa, Viale delle Piagge n. 2, 56124 Pisa, Italy
2 School of Veterinary Medicine and Science, University of Nottingham, Loughborough LE12 5RD, UK